Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.53 USD | +0.15% | +3.84% | -5.19% |
06-06 | Former Takeda Employee Pleads Guilty to Defrauding Company | DJ |
06-06 | Takeda Pharmaceutical Unit Partners with HEALWELL AI for Real-World Evidence Analysis of Hereditary Angioedema | MT |
Sales 2024 | 4,264B 27.36B 2,140B | Sales 2025 * | 4,252B 27.29B 2,134B | Capitalization | 6,594B 42.32B 3,310B |
---|---|---|---|---|---|
Net income 2024 | 144B 925M 72.32B | Net income 2025 * | 116B 747M 58.46B | EV / Sales 2024 | 1.54 x |
Net Debt 2024 * | 3,771B 24.2B 1,893B | Net Debt 2025 * | 4,224B 27.11B 2,121B | EV / Sales 2025 * | 2.54 x |
P/E ratio 2024 |
45.4
x | P/E ratio 2025 * |
59.6
x | Employees | 49,095 |
Yield 2024 |
4.49% | Yield 2025 * |
4.61% | Free-Float | 99.12% |
Latest transcript on Takeda Pharmaceutical Company Limited
1 day | +0.15% | ||
1 week | +3.84% | ||
Current month | +1.35% | ||
1 month | +1.27% | ||
3 months | -7.90% | ||
6 months | -2.94% | ||
Current year | -5.19% |
Managers | Title | Age | Since |
---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 57 | 31/03/14 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 45 | 31/01/22 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 31/12/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 71 | 31/05/16 | |
Ian Clark
BRD | Director/Board Member | 62 | 31/12/18 |
Steven Gillis
BRD | Director/Board Member | 71 | 31/12/18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.42% | 9 M€ | -4.31% | - |
Date | Price | Change | Volume |
---|---|---|---|
06/06/24 | 13.53 | +0.15% | 1,529,591 |
05/06/24 | 13.51 | +0.82% | 1,113,255 |
04/06/24 | 13.4 | +0.30% | 1,814,048 |
03/06/24 | 13.36 | +0.07% | 2,004,235 |
31/05/24 | 13.35 | +2.46% | 1,854,999 |
Delayed Quote Nyse, June 06, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.64% | 749B | |
+39.42% | 605B | |
-6.58% | 351B | |
+19.72% | 328B | |
+8.78% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.03% | 167B | |
+6.13% | 165B |
- Stock Market
- Equities
- 4502 Stock
- TAK Stock